| A landscape of germ line mutations in a cohort of inherited bone marrow failure patients O Bluteau, M Sebert, T Leblanc, R Peffault de Latour, S Quentin, E Lainey, ... Blood, The Journal of the American Society of Hematology 131 (7), 717-732, 2018 | 295 | 2018 |
| A metabolic synthetic lethality of PI3K-driven cancer V Asnafi, G Andrieu, M Simonin, A Cabannes-Hamy, E Lengliné, ... | | 2024 |
| A PEDIATRIC-INSPIRED INTENSIFIED THERAPY OF ADULTS T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA REVEALS THE FAVORABLE OUTCOME OF NOTCH1/FBXW7 MUTATIONS, BUT NOT OF LOW ERG/BAALC … R Ben Abdelali, V Asnafi, A Buzyn, E Lengline, Le noir, S., N Ifrah, ... HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95, 249-249, 2010 | | 2010 |
| Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19 J Delaleu, B Deniau, M Battistella, A de Masson, B Bensaid, M Jachiet, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2777-2779. e1, 2020 | 31 | 2020 |
| Acute kidney injury in critically ill allo-HSCT recipients E Canet, E Lengline, L Zafrani, MN Peraldi, G Socié, E Azoulay Bone marrow transplantation 49 (8), 1121-1122, 2014 | 35 | 2014 |
| ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS WITH NEWLY DIAGNOSED HEMATOLOGICAL MALIGNANCY: PREDICTORS AND LONG-TERM OUTCOME. A PROSPECTIVE ANALYSIS OF 219 CASES E Canet, L Zafrani, V Lemiate, C Algrin, A Seguin, E Lengline, E Mariotte, ... INTENSIVE CARE MEDICINE 37, S238-S238, 2011 | | 2011 |
| Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival E Canet, L Zafrani, J Lambert, C Thieblemont, L Galicier, D Schnell, ... PloS one 8 (2), e55870, 2013 | 137 | 2013 |
| Admission précoce en réanimation chez des patients atteints de leucémie aiguë myéloblastique E Lengliné | | 2010 |
| Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality AS Del Galy, A Marouf, E Raffoux, M Robin, D Michonneau, M Sébert, ... Leukemia 35 (1), 225-228, 2021 | 14 | 2021 |
| Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience G Socie, JE Galimard, E Raffoux, R Itzykson, PE Debureaux, ... Haematologica 108 (9), 2369, 2023 | | 2023 |
| Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia A Contejean, M Resche-Rigon, J Tamburini, M Alcantara, F Jardin, ... Blood 132 (Supplement 1), 1298-1298, 2018 | 28 | 2018 |
| Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment E Lengliné, J Peron, A Vanier, F Gueyffier, S Kouzan, P Dufour, B Guillot, ... The Lancet Oncology 22 (10), e430-e434, 2021 | 33 | 2021 |
| Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis M Cerrano, S Chevret, E Raffoux, F Rabian, M Sébert, S Valade, ... Annals of Hematology 102 (4), 761-768, 2023 | 9 | 2023 |
| Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission I Urbino, E Lengliné, F Rabian, M Cerrano, R Kim, F Chevillon, D Ferrero, ... Blood Advances 8 (10), 2405-2409, 2024 | | 2024 |
| Breast infiltration by relapsed acute lymphoblastic leukaemia on FDG PET/CT A Luzurier, A Van Der Gucht, E Blanc, E Lengline, D Groheux, ... European Journal of Nuclear Medicine and Molecular Imaging 42, 811-812, 2015 | 7 | 2015 |
| C1q helps AML to disseminate and resist E Lengliné Blood, The Journal of the American Society of Hematology 141 (7), 691-692, 2023 | | 2023 |
| Caractéristiques cliniques, évolution à long terme et facteurs prédictifs de rechute après arrêt de l’Imatinib au cours de leucémie chronique à éosinophiles associée au … J Rohmer, JS Bladé, PC Makhoul, V Cottin, M Ebbo, O Fain, L Galicier, ... La Revue de Médecine Interne 42, A57-A58, 2021 | 1 | 2021 |
| Caractéristiques cliniques, évolution à long terme et facteurs prédictifs de rechute après arrêt de l’Imatinib au cours de leucémie chronique à éosinophiles associée au … J Rohmer, JS Bladé, PC Makhoul, V Cottin, M Ebbo, O Fain, L Galicier, ... La Revue de Médecine Interne 41, A70-A71, 2020 | | 2020 |
| Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients E Lengliné, S Chevret, AS Moreau, F Pène, F Blot, JH Bourhis, A Buzyn, ... Bone marrow transplantation 50 (6), 840-845, 2015 | 92 | 2015 |
| Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital N Vallet, S Chevret, L Feghoul, L Aguinaga, L Bondeelle, E Kaphan, ... Blood Cancer Journal 11 (7), 129, 2021 | | 2021 |
